Suchergebnisse - "Noventa, Silvia"

PubPharm (16)

1

Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Militello, A. | Orsi, G. | Cavaliere, A. | +17

2

Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Militello, A. | Orsi, G. | Cavaliere, A. | +17

3

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma

enthalten in: Cancer medicine | 2023

von Procaccio, L. | Merz, V. | Fasano, M. | +21

4

Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv)

enthalten in: British journal of cancer | 2023

von Orsi, G. | Cavaliere, A. | Tortora, G. | +30

5

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma

enthalten in: Cancer Medicine | 2023

von Procaccio, L. | Merz, V. | Fasano, M. | +21

6

Microsatellite instability and chemosensitivity in solid tumours

enthalten in: Therapeutic advances in medical oncology | 2022

von Cherri, S. | Oneda, E. | Noventa, S. | +2

7

Pancreatic adenocarcinoma : Beyond first line, where are we?

enthalten in: World journal of gastroenterology | 2021

von Cherri, S. | Noventa, S. | Zaniboni, A.

8

Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Cascinu, S. | Berardi, R. | Bianco, R. | +22

9

Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era

enthalten in: Cancers | 2021

von Cherri, S. | Noventa, S. | Fanelli, M. | +5

10

Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?

enthalten in: Medical hypotheses | 2020

von Cherri, S. | Noventa, S. | Zaniboni, A.